Sarah Jessica Parker cuts ties with EpiPen after price hike

Sarah Jessica Parker cuts ties with EpiPen after price hike


1 photo
Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

NEW YORK (AP) — Saying she is "disappointed, saddened and deeply concerned" by the price hike of the EpiPen, actress Sarah Jessica Parker has cut ties with the company that makes the emergency allergy treatment.

Parker, whose 13-year-old son James has severe peanut and hazelnut allergies, was part of a short campaign with pharmaceutical giant Mylan N.V., maker of the EpiPen. She was never a spokeswoman.

The company is facing heated criticism about the list price of an EpiPen twin-pack climbing to $608 over the past nine years.

Parker took to Instagram on Thursday to distance herself from the company and urged it to "take swift action to lower the cost to be more affordable for whom it is a life-saving necessity."

A representative for the actress confirmed the statement was accurate.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Photos

Most recent Entertainment stories

The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast